HDL, Inc. Acquires Exclusive U.S. License For Early Lung Cancer Detection Test From Oncimmune Ltd.
watch-a-brief-intro-video-about-early-lung-cancer-detection
watch-the-early-lung-detection-overview-video-for-pulmonologists

85% of lung cancers are diagnosed late stage | EarlyCDT-Lung

85% of lung cancers are diagnosed late stage

EarlyCDT-Lung combined with CT can help.

Learn More
Autoantibodies are detectible up to 5 years before a tumor is visible.

EarlyCDT-Lung:

Panel of autoantibodies to aid in early lung cancer detection

Learn More

When Found Early Stage, 5 Year Survival Rate More Than Triples

Recent NLST Trial further shows 20% mortality improvement. EarlyCDT-Lung can reduce false positives associated with CT.

Learn More

EarlyCDT-Lung is a simple blood test that:

  • Has 5 times better Positive Predictive Value (PPV) than CT
  • Has 7 times fewer false positives than CT
  • Detects all types and all stages of lung cancer, including at the earliest stages
  • Is reimbursed by Medicare Part B and private insurance
  • Moderate or High Level test implies 8x risk of cancer
Learn More

Primary Care Physicians

Your Challenge with Lung Cancer

How to identify the relatively small percentage of lung cancers (5-50 depending on the level of risk), per 1,000, that are present in your high-risk patient population. More….

 

Use of EarlyCDT-Lung:

  • As a diagnostic test to aid in the early detection of lung cancer in your high-risk patients; most notably long-term smokers and ex-smokers.
  • A new tool to stratify pulmonary nodules. More…

Pulmonologists

Your Challenge with Lung Cancer

Stratify patients with pulmonary nodules and other at risk patient populations (ie COPD patients); How to identify the relatively small percentage of lung cancers that are present in your high-risk patient population with pulmonary nodules. More…

Use of EarlyCDT-Lung:
  • Stratify pulmonary nodules especially those where PET is less conclusive.
  • To aid in the early detection of lung cancer in your high-risk patients; most notably long-term smokers and ex-smokers (ie COPD patients). More…

LATEST NEWS

ONCIMMUNE ESTABLISHES SCIENCE COMMITTEE

Oncimmune has established a Science Committee to lead and approve all of the workflow of the Company’s R&D department, ensuring that all research is clearly focused on the interests of the Company.

CLICK HERE FOR COMPANY STATEMENT 

 


Keep up with EarlyCDT...
Your email: